Paving the Way to Better Outcomes

A new kind of study brings good news

Through groundbreaking research, we found that our treatment and prevention methods are helping reduce heart attacks.

chart showing that milder heart attacks declined by 24 percent and serious heart attacks declined by 62 percent.

The decade-long study of more than 46,000 Kaiser Permanente patients in Northern California is the first of its kind to study a large, diverse community. According to Alan S. Go, MD, the results point to the effectiveness of our treatment approach, which includes a low-cost, low-risk combination of medications and healthy lifestyle changes.1


Innovation saving lives

Our researchers are working to save countless lives with a new way of looking at heart attack and stroke prevention — using groundbreaking technology so they can see how the body might respond to disease and treatments.

Our researchers used this technology to see what might happen when a combination of 3 prescription medications was used to prevent heart attacks and strokes.

The results were promising, so we put it into practice. In 3 years, the 3-drug program reduced heart attacks and stroke by 60 percent.2

We've shared our findings with the health care community, and the program has been widely adopted.



Breaking the mold with research

At a time when most cardiac studies involved middle-aged Caucasian men, we broke the mold. Our Coronary Artery Risk Development in Young Adults study (CARDIA) follows participants who are between 18 and 30, and includes African-Americans and Caucasians and both men and women.

Looking at the relationship between lifestyle and heart health, the study has a resulted in a wealth of data on how blood pressure, cholesterol, weight, and lifestyle affect heart health.


For more detailed information about cardiac care, visit

  • 1 Internal Kaiser Permanente Northern California Department of Research study conducted from 1999–2008.
  • 2 Internal Kaiser Permanente Northern California Department of Research study conducted from 2004–2006.